Idiopathic short stature: growth hormone, a therapeutic challenge?

被引：1
作者：
Sultan, C [1 ]
机构：
[1] CHU Montpellier, Serv Pediat 1, Unite Endocrinol Gynecol Pediat, Hop Arnaud Villeneuve, Montpellier, France
[2] CHU Montpellier, Hop Lapeyronie, Serv Hormonol Dev & Reprod, Montpellier, France
[3] CHU Montpellier, Hop Lapeyronie, Unite INSERM U540, Montpellier, France
来源：
ARCHIVES DE PEDIATRIE | 2005年 / 12卷 / 09期
关键词：
growth disorders; drug therapy; growth hormone; therapeutic use;
D O I：
10.1016/j.arcped.2005.05.004
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1317 / 1319
页数：3
相关论文
共 18 条
  • [1] EVIDENCE FOR PARTIAL GROWTH-HORMONE INSENSITIVITY AMONG PATIENTS WITH IDIOPATHIC SHORT STATURE
    ATTIE, KM
    CARLSSON, LMS
    RUNDLE, AC
    SHERMAN, BM
    [J]. JOURNAL OF PEDIATRICS, 1995, 127 (02) : 244 - 250
  • [2] Chan JM, 2002, J NATL CANCER I, V94, P1099
  • [3] Editorial: Growth hormone treatment of "idiopathic short stature": Not so fast
    Freemark, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) : 3138 - 3139
  • [4] MUTATIONS OF THE GROWTH-HORMONE RECEPTOR IN CHILDREN WITH IDIOPATHIC SHORT STATURE
    GODDARD, AD
    COVELLO, R
    LUOH, SM
    CLACKSON, T
    ATTIE, KM
    GESUNDHEIT, N
    RUNDLE, AC
    WELLS, JA
    CARLSSON, LMS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (17) : 1093 - 1098
  • [5] Commentary - Four decades of growth hormone therapy for short children: What have we achieved?
    Guyda, HJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12) : 4307 - 4316
  • [6] Growth hormone insensitivity associated with a STAT5b mutation
    Kofoed, EM
    Hwa, V
    Little, B
    Woods, KA
    Buckway, CK
    Tsubaki, J
    Pratt, KL
    Bezrodnik, L
    Jasper, H
    Tepper, A
    Heinrich, JJ
    Rosenfeld, RG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (12) : 1139 - 1147
  • [7] Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: A randomized, double-blind, placebo-controlled trial
    Leschek, EW
    Rose, SR
    Yanovski, JA
    Troendle, JF
    Quigley, CA
    Chipman, JJ
    Crowe, BJ
    Ross, JL
    Cassorla, FG
    Blum, WF
    Cutler, GB
    Baron, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) : 3140 - 3148
  • [8] A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway
    Lewis, MD
    Horan, M
    Millar, DS
    Newsway, V
    Easter, TE
    Fryklund, L
    Gregory, JW
    Norin, M
    Del valle, CJ
    López-Siguero, JP
    Cañete, R
    López-Canti, LF
    Díaz-Torrado, N
    Espino, R
    Ulied, A
    Scanlon, MF
    Procter, AM
    Cooper, DN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) : 1068 - 1075
  • [9] Growth hormone treatment in non-growth hormone-deficient short children
    Loche, S
    Casini, MR
    Ubertini, GM
    Cappa, M
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (02) : 193 - 198
  • [10] Idiopathic short stature in children
    Miller, BS
    Zimmerman, D
    [J]. PEDIATRIC ANNALS, 2004, 33 (03): : 177 - 181
12